Mrv1909 05201915352D 9 8 0 0 1 0 999 V2000 1.7605 1.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4750 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1895 1.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9039 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6184 1.8414 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 4.6184 2.6664 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.3329 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.0474 1.8414 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.3329 0.6039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 5 4 1 0 0 0 0 5 6 1 6 0 0 0 5 7 1 0 0 0 0 7 8 1 0 0 0 0 7 9 2 0 0 0 0 M END > DB15458 > drugbank > CCCC[C@H](N)C(O)=O > InChI=1S/C6H13NO2/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1 > LRQKBLKVPFOOQJ-YFKPBYRVSA-N > C6H13NO2 > 131.1729 > 131.094628665 > 3 > 22 > 14.457511062054916 > 1 > 2 > 0 > 0 > (2S)-2-aminohexanoic acid > -1.74 > -1.4286287541080052 > -0.17 > 0 > 0 > 0 > 2.7878511623266418 > 9.526564602098674 > 63.31999999999999 > 34.223299999999995 > 4 > 1 > 8.92e+01 g/l > (2R)-14-fluoro-2-methyl-6,9,10,19-tetraazapentacyclo[14.2.1.0^{2,6}.0^{8,18}.0^{12,17}]nonadeca-1(18),8,12(17),13,15-pentaen-11-one > 0 > DB15458 > investigational > Norleucine > L-NORLEUCINE $$$$